120 related articles for article (PubMed ID: 1241912)
1. Effects of disulfiram on the amphetamine-induced behavioral syndrome in the cat as a model of psychosis.
Sudilovsky A
Natl Inst Drug Abuse Res Monogr Ser; 1975 Nov; (3):109-35. PubMed ID: 1241912
[TBL] [Abstract][Full Text] [Related]
2. Apparent hallucinations in monkeys during around-the-clock amphetamine for seven to fourteen days. Possible relevance to amphetamine psychosis.
Nielsen EB; Lyon M; Ellison G
J Nerv Ment Dis; 1983 Apr; 171(4):222-33. PubMed ID: 6834023
[TBL] [Abstract][Full Text] [Related]
3. Critical issues in assessing the behavioral effects of amphetamine.
Rebec GV; Bashore TR
Neurosci Biobehav Rev; 1984; 8(1):153-9. PubMed ID: 6145135
[TBL] [Abstract][Full Text] [Related]
4. Effects of disulfiram, phenoxybenzamine and propranolol on the behaviors evoked by apomorphine and amphetamine in adult cats.
Motles E; Tetas M; Gomez A; Briones C; Gonzalez M
Prog Neuropsychopharmacol Biol Psychiatry; 1992; 16(6):985-1001. PubMed ID: 1513935
[TBL] [Abstract][Full Text] [Related]
5. Amphetamine stereotypy: the influence of environmental factors and prepotent behavioral patterns on its topography and development.
Ellinwood EH; kilbey MM
Biol Psychiatry; 1975 Feb; 10(1):3-16. PubMed ID: 804330
[TBL] [Abstract][Full Text] [Related]
6. Evolving behavior in the clinical and experimental amphetamine (model) psychosis.
Ellinwood EH; Sudilovsky A; Nelson LM
Am J Psychiatry; 1973 Oct; 130(10):1088-93. PubMed ID: 4353974
[No Abstract] [Full Text] [Related]
7. Multiple daily amphetamine administration: behavioral and neurochemical alterations.
Segal DS; Weinberger SB; Cahill J; McCunney SJ
Science; 1980 Feb; 207(4433):905-7. PubMed ID: 7188815
[TBL] [Abstract][Full Text] [Related]
8. Behavioral and EEG changes in the amphetamine model of psychosis.
Ellinwood EH
Adv Biochem Psychopharmacol; 1974; 12(0):281-97. PubMed ID: 4473181
[No Abstract] [Full Text] [Related]
9. [Modification of the behavioral effects of drugs after repeated administration--special reference to the reverse tolerance of amphetamines].
Tadokoro S; Kuribara H
Nihon Yakurigaku Zasshi; 1990 May; 95(5):229-38. PubMed ID: 2191909
[TBL] [Abstract][Full Text] [Related]
10. Methamphetamine-induced behavioural effects and brain concentrations of methamphetamine and its metabolite amphetamine in mice.
Brien JF; Kitney JC; Peachey JE; Rogers BJ
Res Commun Chem Pathol Pharmacol; 1978 Nov; 22(2):313-28. PubMed ID: 569889
[TBL] [Abstract][Full Text] [Related]
11. Repeated binge exposures to amphetamine and methamphetamine: behavioral and neurochemical characterization.
Segal DS; Kuczenski R
J Pharmacol Exp Ther; 1997 Aug; 282(2):561-73. PubMed ID: 9262316
[TBL] [Abstract][Full Text] [Related]
12. Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats.
Paulson PE; Camp DM; Robinson TE
Psychopharmacology (Berl); 1991; 103(4):480-92. PubMed ID: 2062986
[TBL] [Abstract][Full Text] [Related]
13. Behavioral effects of serotonergic and dopaminergic drugs in cats following chronic amphetamine administration.
Trulson ME; Crisp T
Eur J Pharmacol; 1984 Apr; 99(4):313-24. PubMed ID: 6734730
[TBL] [Abstract][Full Text] [Related]
14. Effects of psychostimulant withdrawal on latent inhibition of conditioned active avoidance and prepulse inhibition of the acoustic startle response.
Murphy CA; Di Iorio L; Feldon J
Psychopharmacology (Berl); 2001 Jul; 156(2-3):155-64. PubMed ID: 11549217
[TBL] [Abstract][Full Text] [Related]
15. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis.
Robinson TE; Becker JB
Brain Res; 1986 Jun; 396(2):157-98. PubMed ID: 3527341
[TBL] [Abstract][Full Text] [Related]
16. Partial reversal of stress-induced behavioral sensitization to amphetamine following metyrapone treatment.
Reid MS; Ho LB; Tolliver BK; Wolkowitz OM; Berger SP
Brain Res; 1998 Feb; 783(1):133-42. PubMed ID: 9479062
[TBL] [Abstract][Full Text] [Related]
17. Limited modulation of the abuse-related behavioral effects of d-methamphetamine by disulfiram.
de Moura FB; Kohut SJ; Bergman J
Exp Clin Psychopharmacol; 2018 Oct; 26(5):497-502. PubMed ID: 29963872
[TBL] [Abstract][Full Text] [Related]
18. Amphetamine-induced dopaminergic hypersensitivity in guinea pigs. Implications in psychosis and human movement disorders.
Klawans HL; Margolin DI
Arch Gen Psychiatry; 1975 Jun; 32(6):725-32. PubMed ID: 1130936
[TBL] [Abstract][Full Text] [Related]
19. Time course of the development of the enhanced behavioral and biochemical responses to amphetamine after pretreatment with amphetamine.
Kolta MG; Shreve P; De Souza V; Uretsky NJ
Neuropharmacology; 1985 Sep; 24(9):823-9. PubMed ID: 4058677
[TBL] [Abstract][Full Text] [Related]
20. Methamphetamine-induced behavioral effects and releases of brain catecholamines and brain concentrations of methamphetamine in mice.
Yamanaka Y; Yamamoto T; Egashira T
Jpn J Pharmacol; 1983 Feb; 33(1):33-40. PubMed ID: 6683768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
